Grifols | GRFS - EPS Earnings Per Share

Stock Price
7.86
Daily Change
0.20 2.61%
Monthly
-8.60%
Yearly
1.29%
Q2 Forecast
7.46

Grifols reported EUR0.16 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q1 Mar/2026 0.17 0.17 0.24 May/07




Eps Change Date
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Arca Biopharma USD -0.54 0.14 Dec/2025
aTyr Pharma USD 0.53 0.8 Dec/2025
Bio Path USD -0.07 0.48 Sep/2025
Brainstorm Cell Therapeutics USD -0.19 0.15 Sep/2025
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Cara Therapeutics USD -0.59 4.45 Sep/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Grifols EUR 0.16 0.02 Mar/2026
Immunic USD -0.1 0.03 Dec/2025
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
TherapeuticsMD USD -0.09 0.02 Jun/2024